Printer Friendly

Bergen Brunswig Medical Corporation and Myriad Ultrasound Systems Announce Distribution Agreement.

ATLANTA, Nov. 11 /PRNewswire/ -- Myriad Ultrasound Systems, Inc., a subsidiary of Myriad Ultrasound Systems, Ltd., a manufacturer of ultrasound diagnostic systems which aid in the detection of bone diseases, announced today that the company has signed a marketing and distribution agreement with Bergen Brunswig Medical Corporation, a division of Bergen Brunswig Corporation (NYSE: BBC) of Orange, CA. The two-year agreement calls for Bergen Brunswig Medical to market the SoundScan Compact bone sonometer to office-based physicians nationwide.

"Our new collaboration with Myriad Ultrasound will allow us to offer our primary care customers a sophisticated technology in their own offices that can enhance their ability to detect osteoporosis," said Bill Elliott, President of Bergen Brunswig Medical Corporation. "We look forward to a productive and successful partnership, which will meet our customers' demands for reliable tools that can improve treatment outcomes and reduce care costs."

The SoundScan Compact bone sonometer utilizes quantitative ultrasound measurements of the tibia to assess bone quality. The results are used in conjunction with other risk factors as an aid in the diagnosis of osteoporosis. The SoundScan Compact offers significant advantages over competing technologies, and is designed for use by primary care and other office-based clinicians. The Compact was approved for marketing by the US Food and Drug Administration earlier this year.

"This new agreement represents an important introduction for the SoundScan technology to the primary care marketplace in the United States, and we look forward to demonstrating our commitment to Bergen Brunswig Medical's sales forces," said Danny Adams, Vice President and General Manager, US Marketing and Sales at Myriad Ultrasound.

Bergen Brunswig Corporation, a Fortune 200 company, is one of the nation's leading supply channel management companies. In addition to its diversified healthcare product offerings, the company offers innovative logistics management programs in pharmaceuticals and medical-surgical supplies to all healthcare venues.

Myriad Ultrasound Systems, Inc. regional sales teams provide distribution and marketing support of its ultrasound diagnostic systems for bone disorders in the United States. The company is a wholly-owned subsidiary of Myriad Ultrasound Systems, Ltd., in Rehovot, Israel. Myriad Ultrasound Systems, Ltd., develops and manufactures the SoundScan line of high precision bone assessment systems, which have been installed in hundreds of hospitals, physician offices and research centers worldwide.
COPYRIGHT 1998 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1998 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Geographic Code:1USA
Date:Nov 11, 1998
Words:371
Previous Article:Simon Property Group Announces Third Quarter Results 10.7 Percent Increase in Year-To-Date FFO Per Share.
Next Article:UPMC Study Finds Radiosurgery Effective For Acoustic Tumors.
Topics:

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters